These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 22367345)

  • 1. Posttransplant
    Wang L; Ji K; Chen L; Li Y; Zhu W; Yuan X; Bao X; Wu X; He J
    Front Immunol; 2022; 13():1047200. PubMed ID: 36532004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA Matching in Unrelated Stem Cell Transplantation up to Date.
    Fürst D; Neuchel C; Tsamadou C; Schrezenmeier H; Mytilineos J
    Transfus Med Hemother; 2019 Oct; 46(5):326-336. PubMed ID: 31832058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation.
    Morin-Zorman S; Loiseau P; Taupin JL; Caillat-Zucman S
    Front Immunol; 2016; 7():307. PubMed ID: 27570526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the autoantibody pattern during allogeneic stem-cell transplantation for acute myeloid leukemia complicated by systemic lupus erythematosus.
    Arita K; Murakami J; Wada A; Miyazono T; Sugiyama T
    Bone Marrow Transplant; 2016 Jun; 51(6):883-4. PubMed ID: 26901706
    [No Abstract]   [Full Text] [Related]  

  • 5. Persistence of recipient human leucocyte antigen (HLA) antibodies and production of donor HLA antibodies following reduced intensity allogeneic haematopoietic stem cell transplantation.
    Fasano RM; Mamcarz E; Adams S; Donohue Jerussi T; Sugimoto K; Tian X; Flegel WA; Childs RW
    Br J Haematol; 2014 Aug; 166(3):425-34. PubMed ID: 24750103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luminex(®) and its applications for solid organ transplantation, hematopoietic stem cell transplantation, and transfusion.
    Lachmann N; Todorova K; Schulze H; Schönemann C
    Transfus Med Hemother; 2013 Jun; 40(3):182-9. PubMed ID: 23922543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of HLA antibodies in allogeneic SCT: is the 'type-and-screen' strategy necessary not only for blood type but also for HLA?
    Yoshihara S; Taniguchi K; Ogawa H; Saji H
    Bone Marrow Transplant; 2012 Dec; 47(12):1499-506. PubMed ID: 22231464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo anti-HLA antibody responses after renal transplantation: detection and clinical impact.
    Seveso M; Bosio E; Ancona E; Cozzi E
    Contrib Nephrol; 2009; 162():87-98. PubMed ID: 19001816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT.
    Yoshihara S; Maruya E; Taniguchi K; Kaida K; Kato R; Inoue T; Fujioka T; Tamaki H; Ikegame K; Okada M; Soma T; Hayashi K; Fujii N; Onuma T; Kusunoki Y; Saji H; Ogawa H
    Bone Marrow Transplant; 2012 Apr; 47(4):508-15. PubMed ID: 21691261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
    Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Emergence of donor-derived anti-HLA antibody and subsequent transfusion-refractory thrombocytopenia after allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor in a patient with acute myeloid leukemia].
    Uchiyama Y; Hoshino T; Mihara M; Mitsui T; Koiso H; Takizawa M; Yokohama A; Saitoh T; Uchiumi H; Handa H; Tsukamoto N; Murakami H; Nojima Y
    Rinsho Ketsueki; 2013 Feb; 54(2):214-8. PubMed ID: 23470830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-derived HLA antibody production in patients undergoing SCT from HLA antibody-positive donors.
    Taniguchi K; Yoshihara S; Maruya E; Ikegame K; Kaida K; Hayashi K; Kato R; Inoue T; Fujioka T; Tamaki H; Okada M; Onuma T; Fujii N; Kusunoki Y; Soma T; Saji H; Ogawa H
    Bone Marrow Transplant; 2012 Oct; 47(10):1338-42. PubMed ID: 22367345
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.